In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories Limited (“Ind-Swift”) announced the blockbuster sale of its active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) divisions to Synthimed Labs Private Limited (“Synthimed”) on September 6, 2023. The mega-deal, valued at a whopping INR […]
Ind-Swift Laboratories Limited has agreed to sell its fully-owned Dubai-based subsidiary — Ind-Swift Middle East FZ-LLC (ISME) to UAE-based Soft Air General Trading, for a sum of $1.98 million. Based in Chandigarh, Ind-Swift Laboratories is an active pharmaceutical ingredient (API) and contract research and manufacturing services provider. The turnover of its subsidiary was nil and […]
